- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06478303
Circuitos de imágenes lenguaje-motor para mejorar el aprendizaje motor y la comprensión del lenguaje (LAMI)
Recent evidence suggests that cognitive systems do not operate in isolation but interact within broader networks, thus opening new avenues for fundamental and clinical research. An illustrative example is the interaction between language comprehension and motor representations. For instance, motor training (e.g., sports, origami training) can facilitate action verb recognition, whereas motor deficits (e.g., upper limb immobilization) can hinder the processing of action language. Similarly, action language has been shown to affect motor performance. These effects are attributed to an implicit form of motor imagery, an automatic simulation of motor experience (without actual movement) evoked by action words. Interestingly, literature supports the idea that the motor simulations used for imagining an action are also engaged during the reading of action language, leading to similar neurophysiological and behavioral changes in both processes. However, questions remain about the similarity of the simulations generated by motor imagery and action language. This project, encompassing three experimental sequences, aims to address these questions to achieve significant scientific advancements in both theoretical and applied domains.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Laurent VERCUEIL
- Número de teléfono: 0476765561
- Correo electrónico: LVercueil@chu-grenoble.fr
Copia de seguridad de contactos de estudio
- Nombre: William DUPONT
- Número de teléfono: +33 (0)6 67 76 00 99
- Correo electrónico: william.dupont@univ-grenoble-alpes.fr
Ubicaciones de estudio
-
-
-
Dijon, Francia
- Reclutamiento
- Université de Bourgogne
-
Contacto:
- William DUPONT
- Número de teléfono: +33 (0)6 67 76 00 99
- Correo electrónico: william.dupont@univ-grenoble-alpes.fr
-
Contacto:
- Florent LEBON
- Número de teléfono: +33 (0)3 80 39 67 54
- Correo electrónico: Florent.Lebon@u-bourgogne.fr
-
Investigador principal:
- Florent LEBON
-
-
Grenob
-
Grenoble, Grenob, Francia, 38043
- Reclutamiento
- CHU Grenoble Alpes
-
Investigador principal:
- Laurent VERCUEIL
-
Contacto:
- William DUPONT
- Número de teléfono: +33 (0)6 67 76 00 99
- Correo electrónico: william.dupont@univ-grenoble-alpes.fr
-
Contacto:
- Laurent VERCUEIL
- Número de teléfono: +33 (0)4 76 76 55 61
- Correo electrónico: LVercueil@chu-grenoble.fr
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Subjects will be aged between 18 and 40, reading and understanding French, with no neurological or psychiatric disorders, no uncorrected vision deficits, and meeting all MRI or TMS examination criteria. they were recruited at the University of Burgundy (TMS measures only) and the University of Grenoble Alpes (fMRI measures only).
Descripción
Inclusion Criteria:
- persons who have given written consent,
- healthy subjects
- subjects reading and understanding French
- right-handed,
- affiliated with a social security system,
- between 18 and 40 years old,
- had completed the TMS inclusion questionnaire or had undergone a medical examination prior to participation in the MRI study.
Exclusion Criteria:
- Existence of a severe general medical condition: cardiac, respiratory, hematological, renal, hepatic, cancerous,
- Regular use of anxiolytics, sedatives, antidepressants, neuroleptics,
- Characterized psychiatric pathology,
- Ingestion of alcohol prior to the examination,
- Persons covered by articles L1121-5 to L1121-8 of the CSP,
- Presence of contraindications to MRI or TMS.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: CASE_CONTROL
- Perspectivas temporales: PROSPECTIVE
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
grupo de control
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
Grupo Experimental TMS
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
Grupo experimental de resonancia magnética funcional
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements Participants were asked to perform arm or foot movements |
|
Grupo experimental ccPAS
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
Grupo ccPAS falso
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Level of corticospinal excitability
Periodo de tiempo: 1 hour and 30 minutes
|
this is a physiological response obtained by transcranial magnetic pulses (TMS). This is an indicator of the excitability of the motor system, which can be used at rest or during various cognitive tasks (motor imagery or action reading). |
1 hour and 30 minutes
|
|
Cortical activation (BOLD signal)
Periodo de tiempo: 1 hour
|
this is a cortical response obtained via a fMRI. This is an indicator of the brain activity, which can be used at rest or during motor and cognitive tasks (motor imagery or action reading). |
1 hour
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Laurent VERCUEIL, CHU Grenoble Alpes
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 38RC23.0349
- 2023-A02322-43 (Otro identificador: ID RCB)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .